Clinical Trial Update: Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine

View source ↗

Summary

Completed descriptive post-marketing safety study of the ADACEL vaccine (Tdap) monitoring adverse events under passive surveillance for pertussis; results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pertussis

Drugs mentioned

• ADACEL (Tdap vaccine (tetanus, diphtheria and acellular pertussis vaccine))

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Pertussis | Status: COMPLETED | Results posted: 2016-04-13